Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106


Late-outgrowth endothelial progenitors from patients with coronary artery disease: endothelialization of confluent stromal cell layers.

Fernandez CE, Obi-onuoha IC, Wallace CS, Satterwhite LL, Truskey GA, Reichert WM.

Acta Biomater. 2014 Feb;10(2):893-900. doi: 10.1016/j.actbio.2013.10.004. Epub 2013 Oct 16.


Comparison of endothelial cell phenotypic markers of late-outgrowth endothelial progenitor cells isolated from patients with coronary artery disease and healthy volunteers.

Stroncek JD, Grant BS, Brown MA, Povsic TJ, Truskey GA, Reichert WM.

Tissue Eng Part A. 2009 Nov;15(11):3473-86. doi: 10.1089/ten.TEA.2008.0673.


Characterization of umbilical cord blood-derived late outgrowth endothelial progenitor cells exposed to laminar shear stress.

Brown MA, Wallace CS, Angelos M, Truskey GA.

Tissue Eng Part A. 2009 Nov;15(11):3575-87. doi: 10.1089/ten.TEA.2008.0444.


Adiponectin levels are associated with the number and activity of circulating endothelial progenitor cells in patients with coronary artery disease.

Ying ZQ, Zhong DD, Xu G, Chen MY, Chen QY.

J Zhejiang Univ Sci B. 2009 May;10(5):368-74. doi: 10.1631/jzus.B0820285.


The number of endothelial progenitor cell colonies in the blood is increased in patients with angiographically significant coronary artery disease.

Güven H, Shepherd RM, Bach RG, Capoccia BJ, Link DC.

J Am Coll Cardiol. 2006 Oct 17;48(8):1579-87. Epub 2006 Sep 26.


Statin therapy in patients with coronary artery disease improves the impaired endothelial progenitor cell differentiation into cardiomyogenic cells.

Rupp S, Badorff C, Koyanagi M, Urbich C, Fichtlscherer S, Aicher A, Zeiher AM, Dimmeler S.

Basic Res Cardiol. 2004 Jan;99(1):61-8. Epub 2003 Oct 14.


Effect of intensive lipid-lowering therapy on telomere erosion in endothelial progenitor cells obtained from patients with coronary artery disease.

Satoh M, Minami Y, Takahashi Y, Tabuchi T, Itoh T, Nakamura M.

Clin Sci (Lond). 2009 May 1;116(11):827-35. doi: 10.1042/CS20080404.


Role of extracellular signal-regulated kinase for endothelial progenitor cell dysfunction in coronary artery disease.

Friedrich EB, Werner C, Walenta K, Böhm M, Scheller B.

Basic Res Cardiol. 2009 Sep;104(5):613-20. doi: 10.1007/s00395-009-0022-6. Epub 2009 Apr 12.


Role of endothelial progenitor cells in the beneficial effects of physical exercise on atherosclerosis and coronary artery disease.

Lenk K, Uhlemann M, Schuler G, Adams V.

J Appl Physiol (1985). 2011 Jul;111(1):321-8. doi: 10.1152/japplphysiol.01464.2010. Epub 2011 Feb 24. Review.


Biomechanical effects of flow and coculture on human aortic and cord blood-derived endothelial cells.

Cao L, Wu A, Truskey GA.

J Biomech. 2011 Jul 28;44(11):2150-7. doi: 10.1016/j.jbiomech.2011.05.024. Epub 2011 Jun 16.


Deficiency of the microRNA-31-microRNA-720 pathway in the plasma and endothelial progenitor cells from patients with coronary artery disease.

Wang HW, Huang TS, Lo HH, Huang PH, Lin CC, Chang SJ, Liao KH, Tsai CH, Chan CH, Tsai CF, Cheng YC, Chiu YL, Tsai TN, Cheng CC, Cheng SM.

Arterioscler Thromb Vasc Biol. 2014 Apr;34(4):857-69. doi: 10.1161/ATVBAHA.113.303001. Epub 2014 Feb 20.


Differentiation and proliferation of endothelial progenitor cells from canine peripheral blood mononuclear cells.

Wu H, Riha GM, Yang H, Li M, Yao Q, Chen C.

J Surg Res. 2005 Jun 15;126(2):193-8.


Role of integrin-linked kinase for functional capacity of endothelial progenitor cells in patients with stable coronary artery disease.

Werner C, Böhm M, Friedrich EB.

Biochem Biophys Res Commun. 2008 Dec 12;377(2):331-6. doi: 10.1016/j.bbrc.2008.09.081. Epub 2008 Sep 26.


The biocompatibility of titanium cardiovascular devices seeded with autologous blood-derived endothelial progenitor cells: EPC-seeded antithrombotic Ti implants.

Achneck HE, Jamiolkowski RM, Jantzen AE, Haseltine JM, Lane WO, Huang JK, Galinat LJ, Serpe MJ, Lin FH, Li M, Parikh A, Ma L, Chen T, Sileshi B, Milano CA, Wallace CS, Stabler TV, Allen JD, Truskey GA, Lawson JH.

Biomaterials. 2011 Jan;32(1):10-8. doi: 10.1016/j.biomaterials.2010.08.073. Epub 2010 Nov 5.


Circulating endothelial progenitor cells, C-reactive protein and severity of coronary stenosis in Chinese patients with coronary artery disease.

Wang HY, Gao PJ, Ji KD, Shen WF, Fan CL, Lu L, Zhu DL.

Hypertens Res. 2007 Feb;30(2):133-41.


Genetic engineering with endothelial nitric oxide synthase improves functional properties of endothelial progenitor cells from patients with coronary artery disease: an in vitro study.

Kaur S, Kumar TR, Uruno A, Sugawara A, Jayakumar K, Kartha CC.

Basic Res Cardiol. 2009 Nov;104(6):739-49. doi: 10.1007/s00395-009-0039-x. Epub 2009 May 29.


Reduced levels of putative endothelial progenitor and CXCR4+ cells in coronary artery disease: kinetics following percutaneous coronary intervention and association with clinical characteristics.

Egan CG, Caporali F, Huqi AF, Zito MC, Focardi M, Mondillo S, Pierli C, Marzilli M, Sorrentino V.

Thromb Haemost. 2009 Jun;101(6):1138-46.


Reduced endothelial progenitor cells in European and South Asian men with atherosclerosis.

Hughes AD, Coady E, Raynor S, Mayet J, Wright AR, Shore AC, Kooner JS, Thom SA, Chaturvedi N.

Eur J Clin Invest. 2007 Jan;37(1):35-41.


Construction of tissue-engineered heart valves by using decellularized scaffolds and endothelial progenitor cells.

Fang NT, Xie SZ, Wang SM, Gao HY, Wu CG, Pan LF.

Chin Med J (Engl). 2007 Apr 20;120(8):696-702.


In vivo study of a model tissue-engineered small-diameter vascular bypass graft.

Baguneid M, de Mel A, Yildirimer L, Fuller BJ, Hamilton G, Seifalian AM.

Biotechnol Appl Biochem. 2011 Jan-Feb;58(1):14-24. doi: 10.1002/bab.8.


Supplemental Content

Support Center